This resource includes data on COVID-19 mortality by vaccination status in several countries, including the United States, England, Switzerland, and Chile. Updated weekly. It also explains the impacts of the media’s use of language when reporting COVID-19 deaths.
- Data
This vaccination resource library curated by the National Rural Health Association includes conversation starters and toolkits for addressing health misinformation that can help employers share vaccine facts and improve vaccination access for employees and families.
- Tools & School Guidance
While there is no definitive answer yet, a growing number of studies suggest that getting a COVID vaccine can reduce — though not eliminate — the risk of longer-term symptoms. While the evidence is not yet conclusive, it is clear that vaccines offer protection against infections and hospitalizations, which in turn decreases the chances of getting long COVID.
- Research
Individuals 16 and older who have been fully vaccinated with any FDA-authorized or -approved COVID-19 vaccine for at least 6 months can now get a Pfizer booster shot.
- News
This website contains answers to vaccine-related FAQs in 7 languages, including information on how vaccines protect against variants and information about breakthrough infections. There is also a dedicated section for parents and caregivers, which includes information about how the COVID-19 vaccines work for kids, whether the vaccines are safe, and why doses are different for younger children.
- Tools & School Guidance
This 12-page report includes examples of successful school-located vaccination clinics as well as resources for schools to host their own.
- School Profiles
Contrary to assumptions that the Omicron variant causes milder symptoms, a new large-scale study finds that the Omicron COVID variant is as severe as previous variants after accounting for vaccination status and medical risk factors. The study linked Massachusetts’ state-level vaccination data with quality-controlled electronic health records from a large healthcare system, including 13 hospitals in the state. Findings highlight the efficacy of vaccines in protecting people from severe COVID.
- Research
Omicron Was More Severe for Unvaccinated Children in 5-to-11 Age Group, Study Shows | New York Times
A recent study found that unvaccinated children ages 5-11 were hospitalized with COVID-19 at twice the rate of vaccinated children during the winter Omicron variant surge. Black children accounted for about a third of unvaccinated children, the largest of any racial group.
- Research
The Learning Network helps school and district leaders start or strengthen school COVID-19 testing and vaccination programs. Their website includes key takeaways, video clips, and resources from a series of webinars about running a school COVID-19 testing program. The website also includes an FAQ on using ESSER funding for testing and vaccination at K-12 public schools.
- Tools & School Guidance
A new study from the CDC finds that while the Pfizer vaccination did not protect as well from COVID-19 infection with the omicron variant, they continued to keep most kids aged 5 and older out of the hospital and provide good protection against more severe outcomes.
- Research
This FAQ addresses common questions that parents may have about the safety of COVID-19 vaccines for children. It explains how mRNA vaccines (such as the Pfizer and Moderna vaccines) work and the research that explains why vaccines are now considered safe for young children.
- Tools & School Guidance
This website has guides, templates, and sample messages for district leaders and others to use as part of a public education campaign to increase vaccination rates.
- Tools & School Guidance
Researchers studying the spread of the COVID-19 Omicron variant in England found that people who are vaccinated and received a booster shot are much more likely to be protected from symptomatic infections than those who did not get a booster. The scientists also said that reintroducing safety restrictions could save thousands of lives and spare tens of thousands of people from hospital stays.
- News
The California Department of Public Health announced that they will suspend the implementation of the vaccine mandate in schools for the 2022-23 school year, and will only reconsider the mandate after the vaccine gets full FDA approval for school-age children.
- News
This press release explains the new California public health order for all k-12 public school staff, who must either provide proof of vaccination or submit to weekly testing.
- News
California announces it has 4,000 locations ready to vaccinate children ages 5-11, including 3,100 school-located clinics covering more than 2 million students.
- News
This approval makes another 28 million children eligible for the COVID-19 vaccine, which has been shown to be safe and effective at preventing illness and preventing the spread of the virus in children and adults ages 5 and up.
- News
In addition to describing the risks of COVID-19 infection faced by the unvaccinated, this article also presents the latest research on vaccine efficacy for those who are inoculated. It explains that all approved vaccines continue to provide strong protection for most vaccinated people against hospitalization and death but are less effective in protecting older adults, especially those with underlying medical conditions.
- Research
This webinar discusses safe school reopening strategies, the safety of the vaccine and the need to communicate its effectiveness, and ways that school leaders can provide more in-person education.
- Virtual Training
This interactive tracker displays the number of vaccinations by day and allows visitors to examine individual state rates.
- Data
This free, two-hour online class from Johns Hopkins University provides training that parents of school-age children, teachers, and school staff can use to help them discuss concerns parents and guardians might have about COVID-19 vaccines. The class supports parents in making evidence-based decisions about vaccinating their children.
- Virtual Training
This dashboard aggregates data on pediatric COVID-19 cases, youth vaccination rates, and numbers on schools that are operating in-person, hybrid, or remote.
- Data
This detailed guide offers strategies for how to overcome vaccine hesitancy, such as the use of vaccine ambassadors and motivational interviewing, with concrete examples of these strategies in action.
- Tools & School Guidance
This page, regularly updated with survey analyses, reveals the extent to which parents have vaccinated their children and their attitudes toward mask mandates.
- Data
This toolkit provides several documents and guidance on how to encourage vaccination among staff, including printable posters and social media strategies.
- Tools & School Guidance
With no dissenting votes, an FDA advisory panel provided emergency use authorization for the Pfizer COVID-19 vaccine for children ages 5 to 11. The vaccine has been shown to be more than 90% effective at preventing infections in this age group.
- News
This press release explains that after following 12,000 recipients for 6 months to observe long-term safety outcomes, the FDA has approved the Pfizer-BioNTech COVID-19 vaccine for use in individuals age 16 and older. The vaccine had previously received only emergency use authorization (EUA) for this population. The EUA still applies for individuals age 12 through 15.
- News
This press release explains the science behind the agency's decision to authorize COVID-19 vaccines in youth aged 12 and older after examining the effectiveness of a randomized-control trial of more than 2,000 participants.
- News
This toolkit has resources for organizations and individuals who want to help increase confidence in and uptake of COVID-19 vaccines among high school students. It includes toolkits such as fact sheets about COVID-19 and vaccines, sample text messages to use in outreach to students, tips for students to support vaccination efforts, and guidance on which masks to use and how to wear them correctly.
- Tools & School Guidance
This article highlights how California's aggressive COVID-19 policies, including requiring universal masking in schools and vaccinations for all students and staff, have enabled more schools to stay open. It emphasizes that the most effective way to keep young children safe is for more adults and older siblings and classmates to get vaccinated and reduce the opportunity for the virus to spread among their communities.
- News
This resource provides action steps and resources for school leaders to support COVID-19 vaccine uptake and improve health literacy among staff, students, and families in their community, including setting up a school vaccination clinic and establishing partnerships with community health organizations.
- Tools & School Guidance
This national survey of parents suggests that vaccine uptake among 12-17 year olds may have slowed and shows that a third of parents plan to wait and see before vaccinating their 5-11 year olds. Parents cite vaccine safety and potential side effects as key concerns, and parents of color were more likely to say they faced barriers to vaccine access. Parents receiving vaccine information from their schools were more likely to say their children had been vaccinated.
- Research
This article, which is frequently updated, provides the latest information on vaccination rates by state, race, and ethnicity.
- Research
This article describes how one county became the first to schedule large-scale weekend vaccination events in October and November 2021 in anticipation of emergency use authorization of the Pfizer COVID-19 vaccine by the FDA in children ages 5–11.
- News
This article summarizes recent findings that it is safe to mix and match COVID-19 vaccine types (Johnson & Johnson, Pfizer, and Moderna). It clarifies when and who should receive booster vaccinations based on which vaccine they originally received and on their personal risk factors. It also explains the potential benefits of getting a booster that is different from the original vaccine received.
- News
This news article summarizes two September 2021 CDC reports and emphasizes that pediatric hospitalizations were more than three times higher in less vaccinated states, underscoring the importance of widespread vaccination among eligible adults and children. The studies find that the Delta variant does not appear to cause more severe illness in children but is much more transmissible.
- News
This FAQ states that individuals who have been infected with COVID-19 should still sign up for the vaccine, as re-infection is possible. It also makes clear that the vaccine cannot make individuals sick or alter their DNA.
- Research
This news article describes how more than 18,000 New York City public school teachers elected to receive their first shot the week before an October 4 deadline, mirroring the rush to vaccinate after the city issued a similar mandate for health care workers.
- News
This in-depth case study documents COVID-19 cases that occurred among Marin County, California, elementary school students and their contacts following exposure to an unvaccinated infected teacher. The case highlights the importance of mitigation best practices, including masking and vaccination.
- Research
This CDC study documents breakthrough infections among a cluster of fully vaccinated adults in Massachusetts attending Fourth of July festivities. Of those who had breakthrough infections, four (1.2%) were hospitalized; two of the four had underlying medical conditions.
- Research
This toolkit for parents provides answers to frequently asked questions, talking points, tips, and other science-based information about COVID-19 and vaccines that can be used in conversations and shared in-person or through social media.
- Tools & School Guidance
This peer-reviewed article explains how to establish a school-based vaccination clinic, complete with a sample layout and a list of potential obstacles to consider.
- Research
This research brief summarizes successful mitigation strategies across five California school districts during fall 2021. Strategies include universal testing, test-to-stay quarantine policies, and school-based vaccination clinics.
- School Profiles
This toolkit provides planning and communication resources for schools and immunization partners on school located vaccination clinics. The Association of Immunization Managers was founded in 1999 and is made up of members who are leaders of state, local, and territorial immunization programs in the United States.
- Tools & School Guidance
This website links to several resources for California schools to help administer vaccines, including request forms for mobile pop-up clinics, pharmacists, and volunteers.
- Tools & School Guidance
This study of 7,173 campers and staff members who attended nine different overnight camps around the United States found that with high vaccination coverage and frequent testing, including prearrival screening, there were only nine confirmed cases of COVID-19 and no secondary infections. Each camp also implemented stable cohorts, masking, physical distancing, and hand hygiene.
- Research
This article explains that several studies agree that most COVID-19 vaccines are effective at preventing hospitalization. The Pfizer vaccine remained 88% effective against the Delta virus variant in the UK and 87% effective in Canada.
- News
In modeling the risk–benefit trade-off for vaccinating kids under age 12, researchers at the Food and Drug Administration found that the number of COVID-19 cases prevented by vaccination vastly exceeds the number of myocarditis cases. The model suggests that COVID-19 vaccination will prevent one death per million vaccinated kids; no deaths from myocarditis are expected.
- Research
On March 29, U.S. health officials authorized a second COVID-19 booster dose for people age 50 and older and immunocompromised individuals age 12 and up. The decision comes as scientists have raised concern about the highly contagious and newly predominant BA.2 Omicron subvariant, which has driven up COVID-19 cases in other countries.
- News
On January 3, the U.S. Food and Drug Administration (FDA) authorized the use of a third dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 12 to 15. The FDA also authorized a third shot for children ages 5 to 11 who are immunocompromised.
- News
On Jan 31, 2022, the Food and Drug Administration granted full approval to Moderna’s COVID-19 vaccine, which means that health regulators have completed the same rigorous review of Moderna’s vaccination as dozens of other long-established vaccines. Over 200 million doses of the vaccine have been administered since December 2020, when the FDA authorized the vaccine for emergency use.
- News
This press release summarizes a Kentucky study's findings that unvaccinated individuals who previously had COVID-19 were twice as likely to contract the disease a second time compared to those who were vaccinated.
- Research
This resource contains data on pediatric vaccination rates by state. Vaccination uptake among 5–11 year-olds remains far below its peak before Thanksgiving: just over a quarter (28%) of children ages 5–11 have received at least one COVID-19 vaccine dose nationally. Child vaccination rates also vary widely by state, with the share of fully vaccinated children ranging as high as 52% in Vermont to just 5% in Alabama.
- Data
This chatbot, developed by researchers with expertise in addressing vaccine hesitancy, is designed to answer questions about vaccinations in a nonjudgmental way, particularly for those who might be uncomfortable speaking with friends and family about COVID-19 vaccines, which have been proven to be safe and effective.
- Virtual Training
This webpage provides regular updates on the status of vaccine distribution by state, including numbers of people vaccinated and the number of doses allocated to each state.
- Data
The Workgroup reviewed safety data for the vaccine and finds expanding COVID-19 vaccination to those 5 years and older will protect them against the virus and its variants.
- News
This article, also available as a 4-minute listen, explains that hot spots are now occurring where there are very low rates of vaccination, especially rural areas and small towns.
- News
This news article explains that 65 million pediatric doses have already been purchased to administer to children once FDA approval arrives, which is expected by early November for the Pfizer COVID-19 vaccine.
- News
This study finds that 40% of surveyed Black families and more than 25% of Latino/a families have expressed hesitation about sending their children back to school in the fall, significantly higher proportions than White families. The authors conclude that schools need to continue communicating and consistently reaching out to families about local school safety precautions, virus caseloads, and vaccination rates among teachers and students.
- Research
This article emphasizes that the long-term risks to children from the vaccine are far lower than the risks associated with COVID-19 infection.
- Research